Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Surgery, Georgetown University School of Medicine, Washington, DC, USA.
J Gastrointest Surg. 2018 Sep;22(9):1603-1610. doi: 10.1007/s11605-018-3801-2. Epub 2018 May 7.
Kidney transplant recipients (KTR) are at increased risk of requiring colorectal resection compared to the general population. Given the need for lifelong immunosuppression and the physiologic impact of years of renal replacement, we hypothesized that colorectal resection may be riskier for this unique population.
We investigated the differences in mortality, morbidity, length of stay (LOS), and cost between 2410 KTR and 1,433,437 non-KTR undergoing colorectal resection at both transplant and non-transplant centers using the National Inpatient Sample between 2000 and 2013, adjusting for patient and hospital level factors.
In hospital, mortality was higher for KTR in comparison to non-KTR (11.1 vs 4.3%, p < 0.001; adjusted odds ratio [aOR] 3.59) as were overall complications (38.5 vs 31.5%, p = 0.001; aOR 1.30). LOS was significantly longer (10 vs 7 days, p < 0.001; ratio 1.53) and cost was significantly greater ($23,056 vs $14,139, p < 0.001; ratio 1.54) for KTR compared to non-KTR. While LOS was longer for KTR undergoing resection at transplant centers compared to non-transplant centers (aOR 1.68 vs 1.53, p = 0.03), there were no statistically significant differences in mortality, overall morbidity, or cost by center type.
KTR have higher mortality, higher incidence of overall complications, longer LOS, and higher cost than non-KTR following colorectal resection, regardless of center type. Physicians should consider these elevated risks when planning for surgery in the KTR population and counsel patients accordingly.
与普通人群相比,肾移植受者(KTR)进行结直肠切除术的风险增加。考虑到需要终身免疫抑制以及多年肾脏替代治疗的生理影响,我们假设这种独特人群的结直肠切除术风险更高。
我们使用 2000 年至 2013 年间国家住院样本,调查了在移植和非移植中心接受结直肠切除术的 2410 名 KTR 和 1433437 名非 KTR 之间在死亡率、发病率、住院时间(LOS)和成本方面的差异,同时调整了患者和医院水平的因素。
在医院,KTR 的死亡率明显高于非 KTR(11.1%比 4.3%,p<0.001;调整后的优势比[aOR]3.59),总并发症发生率也更高(38.5%比 31.5%,p=0.001;aOR 1.30)。KTR 的 LOS 明显更长(10 天比 7 天,p<0.001;比值 1.53),成本明显更高(23056 美元比 14139 美元,p<0.001;比值 1.54)。与非移植中心相比,移植中心行结直肠切除术的 KTR 的 LOS 更长(aOR 1.68 比 1.53,p=0.03),但死亡率、总发病率或成本在中心类型上没有统计学上的显著差异。
无论中心类型如何,KTR 在接受结直肠切除术后的死亡率、总并发症发生率、LOS 和成本都高于非 KTR。医生在为 KTR 人群计划手术时应考虑到这些较高的风险,并相应地为患者提供咨询。